Results 181 to 190 of about 9,042 (190)
Some of the next articles are maybe not open access.

cDC1 Prime and Are Licensed by CD4+ T Cells to Induce Anti-Tumour Immunity

Nature, 2020
Robert D. Schreiber   +2 more
exaly  

Immunoactive nanoparticle boosted cDC1 for in situ cancer immunotherapy

PURPOSE: Cancer immunotherapy, which aims to stimulate the immune system to induce antigen specific immune responses against cancers, has emerged as a promising approach for cancer intervention. However, eliciting an effective antitumor immune response is hindered by the scarcity of appropriate antigen-presenting cells (APCs) and their impaired ...
openaire   +1 more source

CDC1

2008
openaire   +1 more source

NCoR1 Fine-Tunes Type-I IFN Response in cDC1 Dendritic Cells by Directly Regulating Myd88-IRF7 Axis Under TLR9

European Journal of Immunology, 2020
Bhawna Gupta   +2 more
exaly  

Differential Chemokine Receptor Expression and Usage by Pre-cDC1 and Pre-cDC2

Immunology and Cell Biology, 2018
Quintin Lee   +2 more
exaly  

cDC1s license CD8+ T cell-mediated neurodegeneration

Nature Reviews Immunology
Jonathan K, Monteiro   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy